Ejiao ameliorates lipopolysaccharide-induced pulmonary inflammation via inhibition of NFκB regulating NLRP3 inflammasome and mitochondrial ROS

• Published in: Biomedicine & pharmacotherapy 2022-08, Vol.152, p.113275-113275, Article 113275
• Main Authors: Yue, Qingxi, Zhang, Wen, Lin, Shumeng, Zheng, Tiansheng, Hou, Yaqin, Zhang, Yanfei, Li, Ziye, Wang, Kai, Yue, Liduo, Abay, Baigenzhin, Li, Ming, Fan, Lihong
• Format: Article
• Language: English
• Subjects: Ejiao; Inflammation; Lipopolysaccharide; Mitochondrial ROS; NFκB; Pyroptosis
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2022.113275

There is no effective treatment for acute lung injury (ALI) at present. Some studies have reported the anti-inflammatory effect of Ejiao, but no study has addressed the underlying action mechanism. In this study, the CCK8 assay displayed Ejiao had a protective effect against LPS-elicited inflammatory lung epithelial Beas 2B cells (LILEB 2B cells). Beas 2B cells treated with LPS and Ejiao were challenged with NFκB inhibitor Bay11–7082 and ROS scavenger N-acetyl cysteine (NAC) alone and in combination. The results of qRT-PCR, Western blotting and fluorescence labeling experiments using Bay11–7082 and NAC demonstrated Ejiao could significantly decrease the expression of p-p65 and p-IκBα in NFκB signaling pathway and its downstream NLRP3, ASC, Caspase-1 and IL-1β related to pyroptosis of LILEB 2B cells. Moreover, Ejiao reduced the production of mitochondrial ROS and reversed the change of mitochondrial membrane potential of LILEB 2B cells. Then, HE staining demonstrated Ejiao had a protective effect against the LPS-elicited ALI mouse model (LAMM). Ejiao also dramatically decreased the cell amount and the overall protein concentration of bronchoalveolar lavage fluid in LAMM. Immunohistochemical staining showed Ejiao remarkably reduced the expression of p-p65 and p-IκBα in NFκB signaling pathway and its downstream NLRP3, ASC, Caspase-1 and IL-1β. The ELISA of IL-1β revealed Ejiao could dose-dependably decrease the concentration of IL-1β in lung tissues, serum and BALF of LAMM. Finally, fluorescence labeling demonstrated Ejiao significantly reduced the mitochondrial ROS generation in the lung tissue of LAMM. This finding may afford a novel strategy for the precaution and therapy of ALI. [Display omitted] •Ejiao ameliorated LPS-induced pulmonary inflammation in vitro and in vivo.•Ejiao inhibited the activation of NFκB and NLRP3 inflammasome and reduced the release of IL-1β.•Ejiao reduced the production of mitochondrial ROS and reversed the change of mitochondrial membrane potential.